UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 12, 2021 4:30 P.M.
Form: S-3
CIK: 0001228627
Company Name: Ocuphire Pharma, Inc.
File Number: 333-252715